Related Experiment Video

Updated: Jul 13, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

Obesity and insulin resistance as risk factors for chronic kidney disease

Adam Whaley-Connell1, Brian S Pavey, Aneesa Afroze

  • 1Department of Internal Medicine, Division of Nephrology, University of Missouri School of Medicine, Columbia, MO, USA. whaleyconnella@health.missouri.edu

Journal of the Cardiometabolic Syndrome
|August 8, 2007
PubMed

Insights

Cardiometabolic syndrome, a cluster of metabolic issues, significantly elevates the risk of kidney disease. Aggressively managing metabolic syndrome risk factors is crucial to prevent progressive loss of kidney function.

Area of Science:

  • Nephrology
  • Cardiology
  • Endocrinology

Background:

  • Cardiometabolic syndrome involves metabolic and vascular dysregulation.
  • It is characterized by insulin resistance, obesity, dyslipidemia, and hypertension.
  • Microalbuminuria signifies systemic endothelial dysfunction and predicts kidney disease progression.

Purpose of the Study:

  • To highlight the link between cardiometabolic syndrome and kidney disease.
  • To emphasize the role of microalbuminuria as a marker of endothelial dysfunction.
  • To underscore the importance of managing metabolic syndrome risk factors for renal health.

Main Methods:

  • Review of existing literature on cardiometabolic syndrome and renal outcomes.
  • Analysis of the clinical components of cardiometabolic syndrome.
  • Examination of the progression from microalbuminuria to overt kidney disease.

Main Results:

  • Cardiometabolic syndrome components collectively increase cardiovascular and renal risk.
  • Visceral obesity and insulin resistance are key drivers of microalbuminuria.
  • Progression to macroalbuminuria indicates evident kidney disease.

Conclusions:

  • Aggressive management of cardiometabolic syndrome risk factors is essential.
  • Nonpharmacologic and pharmacologic interventions can prevent or delay renal function loss.
  • Early intervention is critical to avert chronic kidney disease.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...